Professor Ric Price

Professor of global health; senior principal research fellow; staff specialist in infectious diseases and general medicine, Division of Medicine, Royal Darwin Hospital

Qualifications:

Bachelor of Arts, University of Cambridge, 1983; Bachelor of Medicine and Bachelor of Surgery, University of Cambridge, 1989; Master of Arts, University of Cambridge, 1990; Medical Doctorate, University of London, 2000; Fellow of The Royal Australian College of Physicians, 2004; Fellow of The Royal College of Physicians, UK, 2005; Fellow of The Royal College of Pathologists, UK, 2008; Fellow of the Academy of Medical Science, UK, 2019; ASTMH Distinguished International Fellow, USA, 2020

Approved level of HDR supervision at Charles Darwin University:

Principal Supervisor for PhD

Location:

Darwin - Royal Darwin Hospital campus

Biography:

Professor Ric Price is an infectious disease and general physician on the staff at the Royal Darwin Hospital. He holds a dual academic affiliation as professor of global health at the Menzies School of Health Research and professor of tropical medicine at the Centre of Tropical Medicine, University of Oxford, UK.

He is an expert in malaria therapeutics, antimalarial drug resistance and P. vivax epidemiology with a translational research agenda that spans clinical drug trials, epidemiology, parasitology, molecular biology, social science and health economics.

The ultimate aim of Ric’s research is to change public health policy and impact upon global health outcomes. To achieve this he is coordinating a program involving collaborators from 32 countries, working with local partners to provide the evidence needed to optimise policy and practice, building in-country research capacity and strengthening national malaria surveillance systems to support the global elimination of malaria.

Professor Price chairs the clinical module of the World Wide Antimalarial Resistance Network (WWARN) and between 2010-2020, co-chaired the Vivax Working Group of the Asia-Pacific Malaria Elimination Network (APMEN).

In 2021, Ric was elected as a Fellow of the Australian Academy of Health and Medical Sciences. 

Professor Ric Price
Email
Research Themes
  1. Devine, A., Battle, K. E., Meagher, N., Howes, R. E., Dini, S., Gething, P. W., Simpson, J. A., Price, R. N., & Lubell, Y. (2021). Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study. PLoS medicine, 18(6), e1003614. https://doi.org/10.1371/journal.pmed.1003614
  2. Pfeffer, D. A., Ley, B., Howes, R. E., Adu, P., Alam, M. S., Bansil, P., Boum, Y., Brito, M., Charoenkwan, P., Clements, A., Cui, L., Deng, Z., Egesie, O. J., Espino, F. E., von Fricken, M. E., Hamid, M., He, Y., Henriques, G., Khan, W. A., Khim, N.…Price, R. N. (2020). Quantification of glucose-6-phosphate dehydrogenase activity by spectrophotometry: A systematic review and meta-analysis. PLoS medicine, 17(5), e1003084. https://doi.org/10.1371/journal.pmed.1003084
  3. Taylor, W., Thriemer, K., von Seidlein, L., Yuentrakul, P., Assawariyathipat, T., Assefa, A….Price, R. N. (2019). Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. The Lancet, 394(10202), 929-938. https://doi.org/10.1016/s0140-6736(19)31285-1
  4. Hossain, M. S., Commons, R. J., Douglas, N. M., Thriemer, K., Alemayehu, B. H., Amaratunga, C., Anvikar, A. R., Ashley, E. A., Asih, P., Carrara, V. I., Lon, C., D'Alessandro, U., Davis, T., Dondorp, A. M., Edstein, M. D., Fairhurst, R. M., Ferreira, M. U., Hwang, J., Janssens, B., Karunajeewa, H.…Price, R. N. (2020). The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network. PLoS medicine, 17(11), e1003393. https://doi.org/10.1371/journal.pmed.1003393
  5. Commons, R. J., Simpson, J. A., Thriemer, K., Humphreys, G. S., Abreha, T., Alemu, S. G., Añez, A., Anstey, N. M., Awab, G. R., Baird, J. K., Barber, B. E., Borghini-Fuhrer, I., Chu, C. S., D'Alessandro, U., Dahal, P., Daher, A., de Vries, P. J., Erhart, A., Gomes, M., Gonzalez-Ceron, L.…Price, R. N. (2018). The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis. The Lancet. Infectious diseases, 18(9), 1025–1034. https://doi.org/10.1016/S1473-3099(18)30348-7
  6. Auburn, S., Benavente, E., Miotto, O., Pearson, R., Amato, R., Grigg, M….Price, R. N. (2018). Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics. Nature Communications, 9(1). https://doi.org/10.1038/s41467-018-04965-4
  7. Douglas, N. M., Poespoprodjo, J. R., Patriani, D., Malloy, M. J., Kenangalem, E., Sugiarto, P., Simpson, J. A., Soenarto, Y., Anstey, N. M., & Price, R. N. (2017). Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study. PLoS medicine, 14(8), e1002379. https://doi.org/10.1371/journal.pmed.1002379
  8. Abreha, T., Hwang, J., Thriemer, K., Tadesse, Y., Girma, S., Melaku, Z….Price, R. N. (2017). Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. PLOS Medicine, 14(5), e1002299. https://doi.org/10.1371/journal.pmed.1002299
  9. Price, R. N., von Seidlein, L., Valecha, N., Nosten, F., Baird, J. K., & White, N. J. (2014). Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. The Lancet. Infectious diseases, 14(10), 982–991. https://doi.org/10.1016/S1473-3099(14)70855-2
  10. Ratcliff, A., Siswantoro, H., Kenangalem, E., Maristela, R., Wuwung, R. M., Laihad, F., Ebsworth, E. P., Anstey, N. M., Tjitra, E., & Price, R. N. (2007). Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison. Lancet (London, England), 369(9563), 757–765. https://doi.org/10.1016/S0140-6736(07)60160-3
  11. Price, R. N., Uhlemann, A. C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Patel, R., Laing, K., Looareesuwan, S., White, N. J., Nosten, F., & Krishna, S. (2004). Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet (London, England), 364(9432), 438–447. https://doi.org/10.1016/S0140-6736(04)16767-6
  12. Price, R. N., Nosten, F., Luxemburger, C., ter Kuile, F. O., Paiphun, L., Chongsuphajaisiddhi, T., & White, N. J. (1996). Effects of artemisinin derivatives on malaria transmissibility. Lancet (London, England), 347(9016), 1654–1658. https://doi.org/10.1016/s0140-6736(96)91488-9
Click here to view more Ric Price publications in PubMed.
  1. MEDIA RELEASE | Menzies researchers RESPOND to priority diseases in our global neighbourhood
  2. MEDIA RELEASE | Menzies researchers in the top 2 per cent
  3. The history of Malaria and its global elimination by Professor Ric Price
  4. Largest-ever IPD meta-analysis of malaria patients to inform haemoglobin changes
  5. Public lectures share expert insights in health
  6. Researchers at CDU some of the most influential in their fields
  7. NT News | Territory shares in funding
  8. New insights into immune responses to malaria
  9. New Partnership to Help Eliminate Complex and Persistent Malaria
  10. New Partnership launched to accelerate elimination of relapsing P. vivax malaria
  11. A New $25 Million Unitaid Partnership to Help Eliminate Complex and Persistent Malaria
  12. First study to estimate the global costs due to vivax malaria
  13. MEDIA RELEASE | First study to estimate the global costs due to vivax malaria
  14. Hidden malaria life cycle discovered in the spleen
  15. Finding innovative solutions to eliminate vivax malaria by 2030
  16. CDU academics named among world’s most influential
  17. An open letter from 119 scientists and researchers to The Lancet
  18. Calls for a universal radical cure to treat malaria
  19. Calls for a universal radical cure to treat malaria
  20. Trump’s Faulty Malaria-Coronavirus Connection
  21. Menzies investigators and international collaborators from ACROSS and other institutions have published a meta-analysis
  22. Media Release | Malaria researcher awarded national fellowship
  23. New Research Pinpoints Faster Treatment to Cure Vivax Malaria
  24. New study shows faster way to cure vivax malaria
  25. 7th International Conference on Plasmodium vivax Research | Final Report
  26. Coverage from the 7th International Conference on Plasmodium vivax Research
  27. 50 Top Biomedical And Health Scientists Join Prestigious Academy Of Medical Sciences Fellowship
  28. 50 top biomedical and health scientists join prestigious Academy of Medical Sciences Fellowship
  29. Asia–Pacific research partnerships set to tackle big challenges
  30. SMH | Commonwealth regional research grants key to 'science diplomacy'
  31. ScienceNews | A newly approved drug could be a boon for treating malaria
  32. Improving P. vivax malaria treatment
  33. NT News | Malaria breakthrough for NT
  34. Xinhua News | "Radical cure" best treatment for common malaria: study
  35. New evidence supports radical treatment of widespread form of malaria
  36. Australian support for eliminating malaria and health research in the Indo-Pacific
  37. Malaria victim facing double hand amputation considers legal action against GP
  38. NT News | Brains Trust Born
  39. New Australian-led malaria research powerhouse gears up to hunt down malaria across the Asia-Pacific
  40. Curious Darwin: Why is there no malaria in Australia's northern capital?
  41. Scientists complete the genome sequences of malaria parasites
  42. $2m grant to combat drug resistant malaria and tuberculosis
  43. Burnet Institute Director's Seminar | Part two
  44. Burnet Institute Director's Seminar | Part one
  45. TerritoryQ: War on Malaria, Prof Ric Price and Prof Nicholas Anstey
  46. Research reveals extent of drug resistant vivax malaria
  47. Menzies contributes to key antimalarial recommendations from multinational network
  48. ABC AM: New research into fighting malaria
  49. Radio Australia: Hopes that genetic mapping will outwit malaria parasite
  50. Aljazeera News: Call for global action to tackle Malaria